Cargando…
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) has killed over 2.5 million people worldwide, but effective care and therapy have yet to be discovered. We conducted this analysis to better understand tocilizumab treatment for COVID-19 patients. MAIN TEXT: We searched major databases for manuscripts...
Autores principales: | Wei, Qiu, Lin, Hua, Wei, Rong-Guo, Chen, Nian, He, Fan, Zou, Dong-Hua, Wei, Jin-Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128625/ https://www.ncbi.nlm.nih.gov/pubmed/34001244 http://dx.doi.org/10.1186/s40249-021-00857-w |
Ejemplares similares
-
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis
por: Yin, Jing-Xian, et al.
Publicado: (2023) -
Cost-effectiveness analysis of malaria rapid diagnostic tests: a systematic review
por: Ling, Xiao-Xiao, et al.
Publicado: (2019) -
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials
por: Chen, Musha, et al.
Publicado: (2021) -
Effectiveness of indoor residual spraying on malaria control: a systematic review and meta-analysis
por: Zhou, Yiguo, et al.
Publicado: (2022) -
Spatio-temporal disparities of Clonorchis
sinensis infection in animal hosts in China: a systematic review and meta-analysis
por: Liu, Kai, et al.
Publicado: (2023)